Effectiveness of IFN-gamma for Liver Abscesses in Chronic Granulomatous Disease

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Interferon and Cytokine Research

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/107999099313541PMID 10454340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon Gamma-1b

  2012cited by this paper
• Interleukin‐10 Down‐Regulates Oxidative Metabolism and Antibody‐Dependent Cellular Cytotoxicity of Human Neutrophils

  1997cited by this paper
• Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.

  1996cited by this paper
• Gene transfer to primary chronic granulomatous disease monocytes.

  1995cited by this paper
• Recombinant human interferon-gamma in patients with chronic granulomatous disease —European follow up study

  1995cited by this paper
• Thrombocytopoietic effect of heparin given in chronic immune thrombocytopenic purpura.

  1995cited by this paper
• The Genetic Basis of Chronic Granulomatous Disease

  1994cited by this paper
• Resolution of hepatic abscess after interferon gamma in chronic granulomatous disease.

  1994cited by this paper
• Antitumor response to recombinant murine interferon γ correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophages

  1993cited by this paper
• Resolution of hepatic abscess after interferon gamma in chronic granulomatous disease.

  1993cited by this paper
• Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.

  1992cited by this paper
• Chronic granulomatous disease.

  1992cited by this paper
• Treatment of patients with chronic granulomatous disease with recombinant human interferon‐gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti‐microbial proteins

  1992cited by this paper
• Molecular basis of chronic granulomatous disease [see comments]

  1991cited by this paper
• A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group.

  1991cited by this paper
• Molecular basis of chronic granulomatous disease.

  1991cited by this paper
• Prognosis of chronic granulomatous disease.

  1990cited by this paper
• Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell.

  1990cited by this paper
• Update on chronic granulomatous diseases of childhood. Immunotherapy and potential for gene therapy.

  1990cited by this paper
• Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils.

  1989cited by this paper
• Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.

  1989cited by this paper
• Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon Gamma

  1988cited by this paper
• Clinical features and current management of chronic granulomatous disease.

  1988cited by this paper
• Interferon-gamma, the activated macrophage, and host defense against microbial challenge.

  1988cited by this paper
• In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.

  1987cited by this paper
• Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.

  1987cited by this paper
• Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.

  1986cited by this paper
• Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.

  1985cited by this paper
• Chronic Granulomatous Disease: A Syndrome of Phagocyte Oxidase Deficiencies

  1983cited by this paper
• Pyogenic hepatic abscess in infancy and childhood.

  1978cited by this paper

• Gastrointestinal and Hepatic Manifestations of Chronic Granulomatous Disease.

  2023cites this paper
• Corticosteroid therapy for liver abscesses in a neonate with Chronic granulomatous disease

  2021cites this paper
• Liver Abscess in Chronic Granulomatous Disease—Two Decades of Experience from a Tertiary Care Centre in North-West India

  2021cites this paper
• Infectious Complications in Patients With Chronic Granulomatous Disease.

  2018cites this paper
• Chronic granulomatous disease as an SOS call for multicenter cooperative effort to prevent infections: A meta-analysis of the treatments.

  2016cites this paper
• MRSA Infections in HIV-Infected People Are Associated with Decreased MRSA-Specific Th1 Immunity

  2016influential citation
• Cytokine immunomodulation for the treatment of infectious diseases: lessons from primary immunodeficiencies

  2014cites this paper
• Phänotyp der chronischen Granulomatose assoziiert mit einem schweren G6PD-Mangel in Granulozyten

  2008cites this paper
• The use of interferon-gamma therapy in chronic granulomatous disease.

  2008cites this paper
• Chronic granulomatous disease in pediatric patients: 25 years of experience.

  2007cites this paper
• Chronic granulomatous disease with recurrent hepatic abscesses in an adult.

  2007cites this paper
• Kapitel 22 – Immundefekte

  2007cites this paper
• Immunomodulation for the Prevention and Treatment of Lung Infections

  2004cites this paper
• Immunomodulation for the prevention and treatment of lung infections.

  2004cites this paper
• Cut it out: Managing hepatic abscesses in patients with chronic granulomatous disease.

  2003cites this paper
• Interferon‐γ therapy: Evaluation of routes of administration and delivery systems

  2002cites this paper
• [Gastric outlet obstruction in chronic granulomatous disease].

  2002cites this paper
• Interferon-gamma therapy: evaluation of routes of administration and delivery systems.

  2002cites this paper
• Current treatment options for chronic granulomatous disease

  2002cites this paper
• Akute Magenausgangsstenose - eine Manifestation der septischen Granulomatose

  2002cites this paper
• IFN-γ Is Effective in Reducing Infections in the Mouse Model of Chronic Granulomatous Disease (CGD)

  2001cites this paper
• Clinical aspects of chronic granulomatous disease.

  2001cites this paper